Skip to main content

Progress in Medicinal Chemistry

  • 1st Edition, Volume 42 - April 15, 2004
  • Latest edition
  • Author: F.D. King
  • Language: English

This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of an… Read more

Description

This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of anti-inflammatory and antiapoptotic agents of potential value in rheumatoid arthritis; and a survey of semi-synthetic and totally synthetic antibiotics and anti-HIV agents and their sites of interaction; the development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a description of recent progress in growth hormone secretagogues, with the focus on strategies to improve oral bioavailability and duration of action; and information on inhibition of the proteolytic enzyme, hepatitis C protease N-3(NS3), (required for vital replication) as one of the most attractive targets for HCV infections.

Product details

  • Edition: 1
  • Latest edition
  • Volume: 42
  • Published: April 15, 2004
  • Language: English

About the author

FK

F.D. King

Affiliations and expertise
SmithKIine Beecham Pharmaceuticals New Frontiers Science Park (North) Third Avenue

View book on ScienceDirect

Read Progress in Medicinal Chemistry on ScienceDirect